1281-OR: Risk of Myocardial Infarction (MI) and Ischemic Stroke (IS) following Herpes Zoster (HZ) in Older Adults with T2DM in the U.S.
Diabetes · 08.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-1281-or ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 08.06.2026. Verfasst von NIKITA STEMPNIEWICZ und 5 weiteren Autor:innen.
Themen: Gerontologische Pflege, Schlaganfall
Abstract (Originalsprache)
Introduction and Objective: HZ has been associated with a higher risk of cardiovascular events, but evidence in T2DM is limited. This analysis assessed associations between HZ and MI/IS in older adults with T2DM.
Methods
Using US administrative claims and EHR data (Optum Market Clarity, 2016-2024), adults with T2DM and HZ were identified by ICD-10 diagnosis codes. Four adults with T2DM and no HZ were sampled per HZ case. Index was the first HZ diagnosis or an assigned date for the non-HZ cohort. MI/IS were identified from inpatient ICD-10 diagnosis codes. Crude cumulative MI and IS incidence proportions were described in each cohort among adults aged ≥50 years. Adjusted hazard ratios (HRs) for MI/IS were estimated using Cox proportional hazards models with time-stratified follow-up.
Results
Patients with HZ were older and had greater comorbidity burden than those without HZ (Table). Adjusted HRs, accounting for baseline differences between cohorts, indicated a higher risk of MI following HZ in weeks 1-2 (3.38; 95% CI 2.27-5.02) and months 2-3 (1.45; 1.11-1.90) and a higher risk of IS in weeks 1-2 (7.11; 4.43-11.40), weeks 3-4 (2.08; 1.11-3.89), and months 2-3 (1.49; 1.09-2.05) (Table).
Conclusion
HZ was associated with a short-term increase in MI and IS risk among older adults with T2DM, highest in the first 2 weeks and generally declining thereafter, highlighting a potential additional burden of HZ. Funding: GSK (study identifier VEO-223763). Disclosure N. Stempniewicz: Employee; Current; GlaxoSmithKline plc. Stock/Shareholder; Current; GlaxoSmithKline plc. A. Steffens: Employee; Current; UnitedHealth Group. Other - Optum (of UnitedHealth Group) received funding from GSK for this project.; Current; GlaxoSmithKline plc. Stock/Shareholder; Current; UnitedHealth Group. S. Hague: None. C. Steiger: Other - I am an employee of Optum who has been paid by GSK to complete the analysis for this manuscript.; Current; GlaxoSmithKline plc. P. Koka: Other - GSK paid Optum to perform research. And I am employee to Optum.; Current; GlaxoSmithKline plc. J. Carrico: Employee; Current; GlaxoSmithKline plc.
Zitieren
APA
STEMPNIEWICZ, N., STEFFENS, A., HAGUE, S., STEIGER, C., KOKA, P., & CARRICO, J. (2026). 1281-OR: Risk of Myocardial Infarction (MI) and Ischemic Stroke (IS) following Herpes Zoster (HZ) in Older Adults with T2DM in the U.S. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1281-or
Vancouver
STEMPNIEWICZ N, STEFFENS A, HAGUE S, STEIGER C, KOKA P, CARRICO J. 1281-OR: Risk of Myocardial Infarction (MI) and Ischemic Stroke (IS) following Herpes Zoster (HZ) in Older Adults with T2DM in the U.S. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1281-or
BibTeX
@article{STEMPNIEWICZ2026,
author = {STEMPNIEWICZ, NIKITA and STEFFENS, ANDREA and HAGUE, SARAH and STEIGER, CHRISTINA and KOKA, PRIYANKA and CARRICO, JUSTIN},
title = {1281-OR: Risk of Myocardial Infarction (MI) and Ischemic Stroke (IS) following Herpes Zoster (HZ) in Older Adults with T2DM in the U.S},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-1281-or}
}
EUVIMED